A next generation, high capacity protein A chromatography resin for advanced protein separation in downstream processing.
Amsphere A3 is a next generation Protein A chromatography resin for advanced protein separation in downstream processing of therapeutic antibodies manufacturing.
Besides an outstanding high capacity, Amsphere A3 has an overall improved process robustness, flow characteristics, optimized impurity removal, productivity and resin lifetime.
Join Ying Yao, JSR’s Applications Scientist, for a webinar on comparative purification analysis of Fc-fusion proteins.
Shenzhen, China - September 17, 2021 - Medical and Biological Laboratories Co., Ltd. (President & CEO: Kimimasa Yamada, “MBL”), a JSR Life Sciences Company, announced that its subsidiary MBL Shenzhen Biotech Co., Ltd. (“MBLS”) has been established in full-scale operation as a new R&D and...
Kit will help with understanding immune status of COVID-19 patients and promote research on vaccine efficacy
Tokyo, Japan – August 30, 2021 – Medical Biological Laboratories Co., Ltd., a JSR Life Sciences Company, has released a new RUO kit for measuring neutralizing antibodies against...
Woburn, MA – July 28, 2021 – MBL International, a JSR Life Sciences company, recently announced commercial availability of QuickSwitch™ Class II Custom MHC Tetramer Kits. QuickSwitch kits for Class II MHC Tetramers for analysis of CD4+ T cells have been created to meet the needs of scientists...
Extending the lifetime of Protein A resin during the downstream process of manufacturing a biomolecule can have significant positive effects on your process economy. In this webinar, NaOH in combination with ethylene glycol, ethanol, IPA, and thioglycerol are examined. Bacterial challenge, soaking, and life cycle data on Amsphere A3 resin using PAA will be presented.